News

Conference Update: China Symposium on NAFLD in Shanghai

The symposia on Non-alcoholic Fatty Liver Disease (NAFLD) in Shanghai was co-organised by the China Medical Association and Zhongshan Hospital Fudan University, chaired by Prof Gao Xin.

Read more

Conference Update: Showcasing Resonance Health in Europe

Resonance Health attended or exhibited at three conferences in Europe in June 2015. We profiled both our FerriScan® and HepaFat-Scan® technologies to thousands of delegates and generated almost a hundred leads from around the world.

Read more

Resonance Health News June 2015

Welcome to our June 2015 newsletter. In this issue we have some latest news from the clinical community, details of exciting developments in our R&D department and some new Resonance Health faces to introduce.

To read the full newsletter please click here

 

LIC-NET Italy Advances Best Practice in Iron Monitoring

Headed by Professor Aurelio Maggio (Director of the Department of Haematology and Oncology at Villa Sofia-Cervello Hospital, Palermo, Italy) the Liver Iron Cutino Network (LIC-NET) is a growing network of 12 Italian hospitals working to improve the management of iron overload in patients through accurate assessment of liver iron concentration.

Read more

FerriScan Funding Signals End to Liver Biopsy for Scottish Haemoglobinopathy Patients

The Scottish Paediatric and Adult Haemoglobinopathies Network has secured central funding from the Scottish National Services Directorate for adult patients to access FerriScan R2-MRI (the gold standard measurement of Liver Iron Concentration).

Read more

Resonance Health Partners with CSIRO

We are delighted to announce a new collaboration with one of Australia’s leading research organisations; the Commonwealth Scientific and Industrial Research Organisation (CSIRO), to apply their expertise in our product development pipeline.

Read more